KalVista Pharma VEAL reported third quarter earnings results on Monday, March 11, 2024 at 6:30 AM.
Here’s what investors need to know about the announcement.
Earnings
KalVista Pharma missed earnings estimates by -9.0%, reporting EPS of -$0.84 versus an estimate of -$0.77.
Revenue decreased $0 compared to the same period last year.
Past earnings performance
In the last quarter the company missed EPS by $0.01, followed by a 9.0% drop in the stock price the next day.
** Hear the earnings call for yourself by clicking here. **
To track all earnings releases for KalVista Pharma, visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.